Why it matters: Freestyle Libre is a new continuous blood glucose monitoring system for people with diabetes, which reduces the amount of times a person may need to use a 'finger prick test'. It is relatively expensive, and there has been some debate about its place in therapy. Consequently CCGs originally had different funding policies, although in 2019 NHS England confirmed that national funding was available to offer Freestyle Libre to patients who meet the clinical criteria. In 2020 Freestyle Libre 2, an updated version of the device requiring different sensors was released. Both types of sensor are included in this measure.
Description: Prescribing of Freestyle Libre per 1000 patients
CCGs are ordered by mean percentile over the past six months. Each chart shows the results for the individual CCG, plus deciles across all CCGs in the NHS in England.